Mortality in Korean Patients With Rheumatoid Arthritis

被引:16
作者
Lee, Yeon-Kyung [1 ]
Bae, Sang-Cheol [1 ,2 ]
机构
[1] Hanyang Univ, Inst Rheumatol Res, Seoul, South Korea
[2] Hanyang Univ, Dept Reumatol, Hosp Rheumat Dis, 222 Wangsimni Ro, Seoul 04763, South Korea
来源
JOURNAL OF RHEUMATIC DISEASES | 2021年 / 28卷 / 03期
关键词
Rheumatoid arthritis; Mortality; Republic of Korea; INTERSTITIAL LUNG-DISEASE; METHOTREXATE; COHORT; DEATH; RISK;
D O I
10.4078/jrd.2021.28.3.113
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rheumatoid arthritis (RA) is a chronic inflammatory disease in which the abnormal immune system causes arthritis. We reviewed previous studies about the mortality and causes of death in Korean patients with RA. Also, we discussed the association between comorbidities and mortality in Korean patients with RA. In Korea, a few epidemiologic studies reporting mortality rates in patients with RA have been conducted using large databases. According to these data sources, the estimated mortality rate of Korean patients with RA from 1.29% to 1.65%. Despite substantial improvements in RA management, the mortality rate of patients with RA remains higher than that of the general population. Also, the most common cause of death was malignancy, and respiratory disease and cardiovascular disease followed. The malignancy-specific mortality rate of patient with RA was not higher than that of the general population; however, several causes of death, such as respiratory disease and infections, were associated with a higher mortality rate among patients with RA than among the general population. Therefore, to increase the survival rate of patients with RA, attention should be paid to the management of comorbidities as well as to the RA itself.
引用
收藏
页码:113 / 118
页数:6
相关论文
共 26 条
  • [21] Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
    Alberti, K. G. M. M.
    Eckel, Robert H.
    Grundy, Scott M.
    Zimmet, Paul Z.
    Cleeman, James I.
    Donato, Karen A.
    Fruchart, Jean-Charles
    James, W. Philip T.
    Loria, Catherine M.
    Smith, Sidney C., Jr.
    [J]. CIRCULATION, 2009, 120 (16) : 1640 - 1645
  • [22] Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study
    van den Hoek, J.
    Boshuizen, H. C.
    Roorda, L. D.
    Tijhuis, G. J.
    Nurmohamed, M. T.
    van den Bos, G. A. M.
    Dekker, J.
    [J]. RHEUMATOLOGY INTERNATIONAL, 2017, 37 (04) : 487 - 493
  • [23] Causes of Death in Rheumatoid Arthritis: How Do They Compare to the General Population?
    Widdifield, Jessica
    Paterson, J. Michael
    Huang, Anjie
    Bernatsky, Sasha
    [J]. ARTHRITIS CARE & RESEARCH, 2018, 70 (12) : 1748 - 1755
  • [24] Trends in Excess Mortality Among Patients With Rheumatoid Arthritis in Ontario, Canada
    Widdifield, Jessica
    Bernatsky, Sasha
    Paterson, J. Michael
    Tomlinson, George
    Tu, Karen
    Kuriya, Bindee
    Thorne, J. Carter
    Pope, Janet E.
    Hollands, Simon
    Bombardier, Claire
    [J]. ARTHRITIS CARE & RESEARCH, 2015, 67 (08) : 1047 - 1053
  • [25] Incidence and Risk of Glucocorticoid-Associated Adverse Effects in Patients With Rheumatoid Arthritis
    Wilson, Jessica C.
    Sarsour, Khaled
    Gale, Sara
    Petho-Schramm, Attila
    Jick, Susan S.
    Meier, Christoph R.
    [J]. ARTHRITIS CARE & RESEARCH, 2019, 71 (04) : 498 - 511
  • [26] Patterns of interstitial lung disease and mortality in rheumatoid arthritis
    Zamora-Legoff, Jorge A.
    Krause, Megan L.
    Crowson, Cynthia S.
    Ryu, Jay H.
    Matteson, Eric L.
    [J]. RHEUMATOLOGY, 2017, 56 (03) : 344 - 350